Form 483

Regen Suppliers LLC Form 483, 2025-12-16

FDA issued a Form 483 to Regen Suppliers LLC on 2025-12-16 with 8 public-safe observations.

483· Form 483 issuedBiologics8 observations

Regen Suppliers LLC · Scottsdale, United States · Issued December 16, 2025

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Dec 2025
21 CFR 1271.55(a)(2)

Eligibility statement--basis of determination

Cited by Garrad R Poole, Laurissa S Flowers, Emily S Mcgann

16 Dec 2025
21 CFR 211.130

Procedures are written, and followed

Cited by Garrad R Poole, Laurissa S Flowers, Emily S Mcgann

16 Dec 2025
21 CFR 211.137(d)

Expiration date location on labeling

Cited by Garrad R Poole, Laurissa S Flowers, Emily S Mcgann

16 Dec 2025
21 CFR 211.150(b)

Distribution Recall System

Cited by Garrad R Poole, Laurissa S Flowers, Emily S Mcgann

16 Dec 2025
21 CFR 211.150(b)

Recall facilitation

Cited by Garrad R Poole, Laurissa S Flowers, Emily S Mcgann

Inspected site

RSRegen Suppliers LLCScottsdale, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.150(b)Cited across public-safe Form 483 observations2x
21 CFR 1271.55(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.130Cited across public-safe Form 483 observations1x
21 CFR 211.137(d)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.198(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere